Oncology Biomarker Market Report

Global and China Oncology Biomarker Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 13, 2022
  • PAGES：190
  • REPORT CODE：GMM1369738
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oncology Biomarker industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Genomic Health, Inc

    • Bristol-Myers Squibb

    • Novartis AG

    • GlaxoSmithKline plc

    • Qiagen NV

    • Pfizer, Inc

    • Abbott Laboratories

    • Merck & Co, Inc

    • Eli Lilly and Company FHoffmann-La Roche Ltd

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Prostate Cancer

    • Stomach Cancer

    • Others

    Application:

    • Diagnostics

    • Drug Discovery and Development

    • Prognostics

    • Risk Assessment

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Oncology Biomarker Industry Overview

      • 1.1.1 Oncology Biomarker Market Scope and Market Segments

      • 1.1.2 Oncology Biomarker Industry Characteristics

      • 1.1.3 Global and China Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Oncology Biomarker Production Value and Growth Rate (2017-2028)

    • 1.2 Global Oncology Biomarker Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Lung Cancer

      • 1.2.2 Breast Cancer

      • 1.2.3 Colorectal Cancer

      • 1.2.4 Prostate Cancer

      • 1.2.5 Stomach Cancer

      • 1.2.6 Others

    • 1.3 Global Oncology Biomarker Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Diagnostics

      • 1.3.2 Drug Discovery and Development

      • 1.3.3 Prognostics

      • 1.3.4 Risk Assessment

      • 1.3.5 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Oncology Biomarker Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Oncology Biomarker Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Oncology Biomarker Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Oncology Biomarker Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Oncology Biomarker Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Oncology Biomarker Industry Porter's Five Forces Model Analysis

      • 2.2.3 Oncology Biomarker Industry PEST Analysis

    • 2.3 Oncology Biomarker Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Oncology Biomarker Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Oncology Biomarker Industry

    Chapter 3 Global and China Oncology Biomarker Market, by Manufacturer

    • 3.1 Global and China Oncology Biomarker Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Oncology Biomarker Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Oncology Biomarker Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Oncology Biomarker Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Oncology Biomarker Market Top 3 Players

    Chapter 4 Global and China Oncology Biomarker Market, by Type (2017-2028)

    • 4.1 Oncology Biomarker Market Trend, by Type

    • 4.2 Global Oncology Biomarker Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Oncology Biomarker Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Oncology Biomarker Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Oncology Biomarker Price Trend, by Type (2017-2028)

    • 4.3 China Oncology Biomarker Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Oncology Biomarker Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Oncology Biomarker Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Oncology Biomarker Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Oncology Biomarker Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Oncology Biomarker Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Oncology Biomarker Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Oncology Biomarker Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Oncology Biomarker Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Oncology Biomarker Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Oncology Biomarker Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Oncology Biomarker Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Oncology Biomarker Market Analysis

    • 7.1 North America Oncology Biomarker Market, by Type

    • 7.2 North America Oncology Biomarker Market, by Application

    • 7.3 North America Oncology Biomarker Market Analysis and Forecast, by Country

      • 7.3.1 United States Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Oncology Biomarker Market Analysis

    • 8.1 Europe Oncology Biomarker Market, by Type

    • 8.2 Europe Oncology Biomarker Market, by Application

    • 8.3 Europe Oncology Biomarker Market Analysis and Forecast, by Country

      • 8.3.1 Germany Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Oncology Biomarker Market Analysis

    • 9.1 APAC Oncology Biomarker Market, by Type

    • 9.2 APAC Oncology Biomarker Market, by Application

    • 9.3 APAC Oncology Biomarker Market Analysis and Forecast, by Country

      • 9.3.1 China Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Oncology Biomarker Market Analysis

    • 10.1 Latin America, Middle East and Africa Oncology Biomarker Market, by Type

    • 10.2 Latin America, Middle East and Africa Oncology Biomarker Market, by Application

    • 10.3 Latin America, Middle East and Africa Oncology Biomarker Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Oncology Biomarker Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Oncology Biomarker Company Profiles

      • 11.1 Genomic Health, Inc

        • 11.1.1 Genomic Health, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Genomic Health, Inc Oncology Biomarker Product Profiles, Application and Specification

        • 11.1.3 Genomic Health, Inc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Bristol-Myers Squibb

        • 11.2.1 Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Bristol-Myers Squibb Oncology Biomarker Product Profiles, Application and Specification

        • 11.2.3 Bristol-Myers Squibb Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Novartis AG

        • 11.3.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Novartis AG Oncology Biomarker Product Profiles, Application and Specification

        • 11.3.3 Novartis AG Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 GlaxoSmithKline plc

        • 11.4.1 GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 GlaxoSmithKline plc Oncology Biomarker Product Profiles, Application and Specification

        • 11.4.3 GlaxoSmithKline plc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Qiagen NV

        • 11.5.1 Qiagen NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Qiagen NV Oncology Biomarker Product Profiles, Application and Specification

        • 11.5.3 Qiagen NV Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer, Inc

        • 11.6.1 Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer, Inc Oncology Biomarker Product Profiles, Application and Specification

        • 11.6.3 Pfizer, Inc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Abbott Laboratories

        • 11.7.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Abbott Laboratories Oncology Biomarker Product Profiles, Application and Specification

        • 11.7.3 Abbott Laboratories Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Merck & Co, Inc

        • 11.8.1 Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Merck & Co, Inc Oncology Biomarker Product Profiles, Application and Specification

        • 11.8.3 Merck & Co, Inc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Eli Lilly and Company FHoffmann-La Roche Ltd

        • 11.9.1 Eli Lilly and Company FHoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Product Profiles, Application and Specification

        • 11.9.3 Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Oncology Biomarker Industry Investment Prospect and Risk Assessment

    • 12.1 Oncology Biomarker Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Oncology Biomarker Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure China Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Global Oncology Biomarker Production Value and Growth Rate (2017-2028)

    • Figure China Oncology Biomarker Production Value and Growth Rate (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Lung Cancer (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Breast Cancer (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Colorectal Cancer (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Prostate Cancer (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Stomach Cancer (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Diagnostics (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Drug Discovery and Development (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Prognostics (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Risk Assessment (2017-2028)

    • Figure Global Oncology Biomarker Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Oncology Biomarker Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Oncology Biomarker Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Oncology Biomarker Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Oncology Biomarker Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Oncology Biomarker Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Oncology Biomarker Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Oncology Biomarker Market Share, by Manufacturer in 2021

    • Figure Global and China Oncology Biomarker Market Share, by Manufacturer in 2022

    • Table Global Oncology Biomarker Sales Volume, by Type (2017-2028)

    • Table Global Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure Global Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Table Global Oncology Biomarker Sales Value, by Type (2017-2028)

    • Table Global Oncology Biomarker Sales Value Share, by Type (2017-2028)

    • Figure Global Oncology Biomarker Price Trend, by Type (2017-2028)

    • Table China Oncology Biomarker Sales Volume, by Type (2017-2028)

    • Table China Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure China Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Table China Oncology Biomarker Sales Value, by Type (2017-2028)

    • Table China Oncology Biomarker Sales Value Share, by Type (2017-2028)

    • Figure China Oncology Biomarker Price Trend, by Type (2017-2028)

    • Table Global Oncology Biomarker Sales Volume, by Application (2017-2028)

    • Table Global Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Global Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Table Global Oncology Biomarker Sales Value, by Application (2017-2028)

    • Table Global Oncology Biomarker Sales Value Share, by Application (2017-2028)

    • Figure Global Oncology Biomarker Sales Value Share, by Application (2017-2028)

    • Table China Oncology Biomarker Sales Volume, by Application (2017-2028)

    • Table China Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure China Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Table China Oncology Biomarker Sales Value, by Application (2017-2028)

    • Table China Oncology Biomarker Sales Value Share, by Application (2017-2028)

    • Figure China Oncology Biomarker Sales Value Share, by Application (2017-2028)

    • Figure China Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure North America Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Oncology Biomarker Production, Import, Consumption and Export (2017-2022)

    • Table North America Oncology Biomarker Sales Volume, by Type (2017-2028)

    • Table North America Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure North America Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Table North America Oncology Biomarker Sales Volume, by Application (2017-2028)

    • Table North America Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure North America Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure United States Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure United States Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Canada Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Table Europe Oncology Biomarker Sales Volume, by Type (2017-2028)

    • Table Europe Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure Europe Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Table Europe Oncology Biomarker Sales Volume, by Application (2017-2028)

    • Table Europe Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Europe Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Germany Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure UK Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure UK Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure France Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure France Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Italy Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Spain Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Poland Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Russia Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Table APAC Oncology Biomarker Sales Volume, by Type (2017-2028)

    • Table APAC Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure APAC Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Table APAC Oncology Biomarker Sales Volume, by Application (2017-2028)

    • Table APAC Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure APAC Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure China Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure China Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Japan Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure India Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure India Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Oncology Biomarker Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Oncology Biomarker Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Oncology Biomarker Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Oncology Biomarker Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Oncology Biomarker Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Oncology Biomarker Sales Value and Growth Rate (2017-2028)

    • Table Genomic Health, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genomic Health, Inc Product Profiles, Application and Specification

    • Table Genomic Health, Inc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline plc Product Profiles, Application and Specification

    • Table GlaxoSmithKline plc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Qiagen NV Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Qiagen NV Product Profiles, Application and Specification

    • Table Qiagen NV Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer, Inc Product Profiles, Application and Specification

    • Table Pfizer, Inc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck & Co, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck & Co, Inc Product Profiles, Application and Specification

    • Table Merck & Co, Inc Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly and Company FHoffmann-La Roche Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly and Company FHoffmann-La Roche Ltd Product Profiles, Application and Specification

    • Table Eli Lilly and Company FHoffmann-La Roche Ltd Oncology Biomarker Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US